Laurus Labs Limited (LAURUSLABS.NS)
INR 628.05
(0.18%)
INR 628.05
(0.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.9 Billion INR | -40.39% |
| 2022 | 19.98 Billion INR | 36.15% |
| 2021 | 14.67 Billion INR | 24.47% |
| 2020 | 11.79 Billion INR | 26.06% |
| 2019 | 9.35 Billion INR | 22.24% |
| 2018 | 7.65 Billion INR | 23.86% |
| 2017 | 6.17 Billion INR | 14.83% |
| 2016 | 5.37 Billion INR | 74.7% |
| 2015 | 3.07 Billion INR | 38.74% |
| 2014 | 2.21 Billion INR | 25.97% |
| 2013 | 1.76 Billion INR | 29.91% |
| 2012 | 1.35 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.12 Billion INR | -0.69% |
| 2024 Q2 | 6.04 Billion INR | 93.23% |
| 2023 Q4 | 3.15 Billion INR | -44.38% |
| 2023 FY | 11.9 Billion INR | -40.39% |
| 2023 Q1 | 5.21 Billion INR | 6.95% |
| 2023 Q2 | 5.48 Billion INR | 5.21% |
| 2023 Q3 | 5.66 Billion INR | 3.21% |
| 2022 Q4 | 4.87 Billion INR | -3.66% |
| 2022 Q1 | 5.02 Billion INR | 63.54% |
| 2022 Q2 | 5.01 Billion INR | -0.24% |
| 2022 FY | 19.98 Billion INR | 36.15% |
| 2022 Q3 | 5.06 Billion INR | 0.98% |
| 2021 Q3 | 3.83 Billion INR | -1.4% |
| 2021 Q2 | 3.88 Billion INR | 0.27% |
| 2021 FY | 14.67 Billion INR | 24.47% |
| 2021 Q1 | 3.87 Billion INR | 65.06% |
| 2021 Q4 | 3.07 Billion INR | -19.86% |
| 2020 Q3 | 3.3 Billion INR | 5.08% |
| 2020 FY | 11.79 Billion INR | 26.06% |
| 2020 Q1 | 2.98 Billion INR | 80.1% |
| 2020 Q4 | 2.34 Billion INR | -28.94% |
| 2020 Q2 | 3.14 Billion INR | 5.34% |
| 2019 Q1 | 2.38 Billion INR | 90.29% |
| 2019 FY | 9.35 Billion INR | 22.24% |
| 2019 Q4 | 1.65 Billion INR | -38.2% |
| 2019 Q3 | 2.68 Billion INR | 2.26% |
| 2019 Q2 | 2.62 Billion INR | 10.02% |
| 2018 Q1 | 2.01 Billion INR | 7.73% |
| 2018 Q4 | 1.25 Billion INR | -37.47% |
| 2018 FY | 7.65 Billion INR | 23.86% |
| 2018 Q3 | 2 Billion INR | -15.66% |
| 2018 Q2 | 2.37 Billion INR | 17.98% |
| 2017 Q1 | 1.65 Billion INR | 0.41% |
| 2017 FY | 6.17 Billion INR | 14.83% |
| 2017 Q2 | 1.74 Billion INR | 5.3% |
| 2017 Q3 | 1.76 Billion INR | 1.16% |
| 2017 Q4 | 1.87 Billion INR | 5.8% |
| 2016 Q4 | 1.65 Billion INR | 8.1% |
| 2016 Q1 | 1.36 Billion INR | 0.0% |
| 2016 FY | 5.37 Billion INR | 74.7% |
| 2016 Q3 | 1.52 Billion INR | 1.16% |
| 2016 Q2 | 1.51 Billion INR | 10.46% |
| 2015 FY | 3.07 Billion INR | 38.74% |
| 2014 FY | 2.21 Billion INR | 25.97% |
| 2013 FY | 1.76 Billion INR | 29.91% |
| 2012 FY | 1.35 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hester Biosciences Limited | 908.84 Million INR | -1210.44% |
| Albert David Limited | 1.02 Billion INR | -1060.633% |
| Alembic Limited | 872.45 Million INR | -1265.086% |
| Alkem Laboratories Limited | 32.83 Billion INR | 63.728% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 24.953% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -2514.177% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1108.693% |
| FDC Limited | 3.49 Billion INR | -240.304% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -2.312% |
| Gufic Biosciences Limited | 1.18 Billion INR | -903.701% |
| Hikal Limited | 4.46 Billion INR | -166.809% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -460.676% |
| Ind-Swift Limited | 946.56 Million INR | -1158.21% |
| Innova Captab Limited | 931.03 Million INR | -1179.207% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -2615.722% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 17.602% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -2787.735% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1008.728% |
| Lupin Limited | 125.09 Billion INR | 90.479% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -7241.396% |
| Medico Remedies Limited | 59.67 Million INR | -19857.771% |
| Morepen Laboratories Limited | 1.98 Billion INR | -499.25% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1176.916% |
| Orchid Pharma Limited | 800.77 Million INR | -1387.292% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -297.603% |
| RPG Life Sciences Limited | 1.63 Billion INR | -628.205% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -366.301% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 92.275% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -749.009% |
| Themis Medicare Limited | 1.12 Billion INR | -957.898% |
| Unichem Laboratories Limited | 6.72 Billion INR | -77.075% |
| Vaishali Pharma Limited | 84.02 Million INR | -14073.44% |
| Venus Remedies Limited | 1.91 Billion INR | -521.505% |
| Wanbury Limited | 978.96 Million INR | -1116.569% |
| Windlas Biotech Limited | 1 Billion INR | -1083.277% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1075.629% |
| Ipca Laboratories Limited | 18.98 Billion INR | 37.276% |
| Aarti Drugs Limited | 1.16 Billion INR | -920.13% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -287.386% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -174530.499% |
| Brooks Laboratories Limited | 51.18 Million INR | -23170.418% |
| Eris Lifesciences Limited | 4.94 Billion INR | -140.946% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -441.109% |
| Sigachi Industries Limited | 579.88 Million INR | -1953.814% |
| Sakar Healthcare Limited | 204.07 Million INR | -5735.877% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 78.602% |
| Divi's Laboratories Limited | 14.17 Billion INR | 15.951% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -381.496% |
| Mankind Pharma Limited | 29.27 Billion INR | 59.315% |
| Sequent Scientific Limited | 2.9 Billion INR | -310.427% |
| Neuland Laboratories Limited | 2.92 Billion INR | -306.513% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 19.488% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 74.634% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 90.488% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -468.748% |
| Wockhardt Limited | 8.48 Billion INR | -40.446% |
| Bal Pharma Limited | 555.62 Million INR | -2043.492% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 87.578% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -739.178% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -20332.672% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -447.703% |
| Shilpa Medicare Limited | 3.33 Billion INR | -257.204% |
| Valiant Laboratories Limited | 138.02 Million INR | -8528.477% |
| Ajanta Pharma Limited | 30.46 Billion INR | 60.904% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -83695.117% |
| Granules India Limited | 10.31 Billion INR | -15.486% |
| Medicamen Biotech Limited | 335.16 Million INR | -3453.393% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -3345.794% |
| Piramal Enterprises Limited | 63.65 Billion INR | 81.289% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 44.404% |
| NATCO Pharma Limited | 10.05 Billion INR | -18.411% |
| Suven Life Sciences Limited | 109.75 Million INR | -10751.754% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -25703.363% |
| Strides Pharma Science Limited | 9.16 Billion INR | -29.987% |
| Indoco Remedies Limited | 12.06 Billion INR | 1.255% |
| Alpa Laboratories Limited | 127.38 Million INR | -9249.819% |
| Lasa Supergenerics Limited | 291.17 Million INR | -3990.269% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -287.084% |